Should we routinely use mupirocin to prevent staphylococcal infections?

Virginia R. Roth*, Cathryn Murphy, Trish M. Perl, Alfred DeMaria, Annette H. Sohn, Ronda L. Sinkowitz-Cochran, William R. Jarvis

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

3 Citations (Scopus)

Abstract

Routine use of mupirocin to prevent staphylococcal infections is controversial. We assessed attitudes and practices of healthcare professionals attending the Fourth Decennial International Conference on Nosocomial and Healthcare-Associated Infections regarding mupirocin prophylaxis. Eighty percent of participants did not use mupirocin routinely. At the end of the session, 58% indicated they would consider increased use of mupirocin.

Original languageEnglish
Article number04423
Pages (from-to)745-749
Number of pages5
JournalInfection Control and Hospital Epidemiology
Volume21
Issue number11
DOIs
Publication statusPublished - 1 Jan 2000
Externally publishedYes

    Fingerprint

Cite this

Roth, V. R., Murphy, C., Perl, T. M., DeMaria, A., Sohn, A. H., Sinkowitz-Cochran, R. L., & Jarvis, W. R. (2000). Should we routinely use mupirocin to prevent staphylococcal infections? Infection Control and Hospital Epidemiology, 21(11), 745-749. [04423]. https://doi.org/10.1086/501720